Brain Tumor
Showing 8 of 11 results
Tiny Lab-Generated Microtumors Could Revolutionize Brain Cancer Treatment
UH Clinical Update | October 2024
UH Introduces Stealth Autoguide™ for Precision Neurosurgery
New robotic guidance platform reduces risk for patients undergoing complex brain surgery - Innovations in Neurology & Neurosurgery | Winter 2021
UH Seidman Cancer Center Opens New Trial with PVSRIPO, a Viral-based Immunotherapy in Combination with Pembrolizumab for Patients with Recurrent GBM
The two therapies may be able to generate a potent and specific anti-tumor response in rGBM patients, given their different but complimentary mechanisms of action - Innovations in Cancer | Fall 2020
CETNO Advances Brain Tumor Translational Research from the Basic Science into Clinical Care
UH Research & Education Update | July 2020
UH Neurosurgeon Testing Novel Gene Therapy Treatment for Glioblastoma
New $2.7 million grant from the National Cancer Institute will help validate promising approach - Innovations in Cancer | Summer 2019
5-ALA: Giving Surgeons an Edge
5-ALA helps surgeons visualize boundaries of invading tumors for more complete removal - Innovations in Neurology & Neurosurgery - Winter 2019
Newly FDA-approved Imaging Agent That Makes Brain Tumors Glow Hot Pink
Distinguishes tumor from healthy tissue to improve tumor removal The imaging agent 5-Aminolevulinic Acid (5-ALA), which helps neurosurgeons see the edges of a tumor more clearly to improve removal, was used in brain cancer surgery at University...
Multi-Disciplinary Care for Patients with Primary and Metastatic Tumors of the Brain & Spine
UH Neurological Institute - Summer 2018 University Hospital’s Neurological Institute works closely with UH Seidman Cancer Center to offer cutting-edge treatments for primary and metastatic cancers of the brain and spine and for non-metastatic...